A detailed history of Evanson Asset Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Evanson Asset Management, LLC holds 1,505 shares of LLY stock, worth $1.23 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,505
Previous 1,412 6.59%
Holding current value
$1.23 Million
Previous $1.28 Million 4.3%
% of portfolio
0.1%
Previous 0.1%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$772.14 - $960.02 $71,809 - $89,281
93 Added 6.59%
1,505 $1.33 Million
Q2 2024

Jul 12, 2024

BUY
$724.87 - $909.04 $47,116 - $59,087
65 Added 4.83%
1,412 $1.28 Million
Q1 2024

Apr 12, 2024

BUY
$592.2 - $792.28 $40,269 - $53,875
68 Added 5.32%
1,347 $1.05 Million
Q4 2023

Jan 18, 2024

BUY
$525.19 - $619.13 $29,410 - $34,671
56 Added 4.58%
1,279 $745,000
Q3 2023

Oct 19, 2023

BUY
$434.7 - $599.3 $5,216 - $7,191
12 Added 0.99%
1,223 $656,000
Q2 2023

Jul 10, 2023

BUY
$350.74 - $468.98 $84,177 - $112,555
240 Added 24.72%
1,211 $567,000
Q1 2023

Apr 12, 2023

BUY
$310.63 - $364.82 $81,074 - $95,218
261 Added 36.76%
971 $333,000
Q4 2022

Jan 12, 2023

SELL
$321.55 - $374.67 $89,712 - $104,532
-279 Reduced 28.21%
710 $0
Q3 2022

Oct 12, 2022

BUY
$296.48 - $337.87 $71,451 - $81,426
241 Added 32.22%
989 $320,000
Q4 2021

Jan 19, 2022

BUY
$224.85 - $279.04 $168,187 - $208,721
748 New
748 $207,000
Q2 2020

Jul 13, 2020

SELL
$136.42 - $164.18 $320,314 - $385,494
-2,348 Closed
0 $0
Q3 2019

Oct 11, 2019

SELL
$106.79 - $116.16 $3,096 - $3,368
-29 Reduced 1.22%
2,348 $263,000
Q2 2019

Jul 11, 2019

BUY
$110.79 - $129.32 $6,647 - $7,759
60 Added 2.59%
2,377 $263,000
Q4 2018

Jan 17, 2019

BUY
$105.9 - $118.64 $245,370 - $274,888
2,317 New
2,317 $268,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $778B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Evanson Asset Management, LLC Portfolio

Follow Evanson Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evanson Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evanson Asset Management, LLC with notifications on news.